ucsf logo

Christopher Showers, MD

Kidney Disease (Nephrology) Parnassus
415-353-2507
ucsf logo

Christopher Showers, MD

Kidney Disease (Nephrology) Parnassus
415-353-2507

On this page

Education & training

Board certification

  • Nephrology, American Board of Internal Medicine/Nephrology
  • Internal Medicine, American Board of Internal Medicine

Residency

  • Internal Medicine, New York - Presbyterian Queens Hospital

Internship

  • Internal Medicine, New York - Presbyterian Queens Hospital

Degree

  • MD, American University of Antigua College of Medicine

Academic title

  • Health Sciences Clinical Professor

Locations

    My research

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    83 ratings
    About provider reviews

    Showing 1-6 of 18 reviews

    Sort by
    • 5 out of 5 Stars
      July 20, 2026

      I am lucky with my provider

    • 5 out of 5 Stars
      July 9, 2026

      Dr. Showers was terrific throughout the video call. Despite it being my first interaction with him, he showed a thorough knowledge of my medical history. He explained my blood labs clearly and was patient in answering all my questions. The visit never felt hurried. Excellent visit.

    • 5 out of 5 Stars
      July 9, 2026

      I find that Dr. Showers is exceptional in his practice! I feel I have the best of care.

    • 4 out of 5 Stars
      June 5, 2026

      Good

    • 5 out of 5 Stars
      June 3, 2026

      Excellent perfect very well

    • 5 out of 5 Stars
      May 12, 2026

      The Doctor was so nice, and listened to all of my concerns. I was so excited with knowing that he was going to be part of my team of doctors.

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.